US Stock MarketDetailed Quotes
TSVT 2seventy bio
- 4.290
- +0.020+0.47%
Close Apr 25 16:00 ET
- 4.290
- 0.0000.00%
Post 18:32 ET
220.12MMarket Cap-970P/E (TTM)
4.350High3.440Low3.73MVolume4.000Open4.270Pre Close14.15MTurnover7.51%Turnover RatioLossP/E (Static)51.31MShares12.69052wk High0.86P/B212.83MFloat Cap1.53552wk Low--Dividend TTM49.61MShs Float64.000Historical High--Div YieldTTM21.30%Amplitude1.535Historical Low3.798Avg Price1Lot Size
About 2seventy bio Company
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Company Profile
SymbolTSVT
Company Name2seventy bio
Listing DateOct 18, 2021
Founded2021
CEOMr. Nick Leschly
MarketNASDAQ
Employees274
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address60 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-339-499-9300
Websitehttp://www.2seventybio.com
Company Executives
- Name
- Position
- Salary
- Nick Leschly
- President, Chief Executive Officer and Director
- 6.08M
- William D. Baird, III
- Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
- 9.20M
- Victoria Eatwell
- Senior Vice President, Finance
- --
- Dr. Wei Lin
- Director
- --
- Charles Newton
- Independent Director
- --
- Sarah Glickman
- Independent Director
- 253.54K
- Dr. Marcela V. Maus
- Independent Director
- 242.42K
- Eli D. Casdin, M.B.A.
- Independent Director
- --
- Denice M. Torres, J.D.,M.B.A.
- Independent Director
- 330.51K
- Daniel S. Lynch, M.B.A.
- Independent Director
- 327.57K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg